Related Experiment Video
Updated: Apr 16, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Glomerulonephritis-Induced Changes in Urinary and Kidney MicroRNA Profiles in Rats
Mira Pavkovic1, Björn Riefke2, Anna-Lena Frisk2
1*Investigational Toxicology, GDD-GED-Toxicology, Bayer Pharma AG, 42096 Wuppertal, Germany, Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, 02115 Boston, Massachusetts, Pathology, GDD-GED-Toxicology, Bayer Pharma AG, 13353 Berlin, Germany and Indication Expansion, GDD-GTRG-Cross Indication Platform, Bayer Pharma AG, 13353 Berlin, Germany *Investigational Toxicology, GDD-GED-Toxicology, Bayer Pharma AG, 42096 Wuppertal, Germany, Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, 02115 Boston, Massachusetts, Pathology, GDD-GED-Toxicology, Bayer Pharma AG, 13353 Berlin, Germany and Indication Expansion, GDD-GTRG-Cross Indication Platform, Bayer Pharma AG, 13353 Berlin, Germany.
Abstract:
MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and thus are involved in various physiological and pathological states. Due to their stability in biofluids miRNAs have also been proposed as biomarkers (BMs) for tissue injury. We investigated the usefulness of urinary miRNAs for detection of site-specific renal damage in an antiglomerular basement membrane glomerulonephritis (GN) model in rats by comparing GN-induced urinary miRNAs profiles to traditional and newer protein BMs, and to proximal tubular injury-induced urinary miRNA profiles observed previously after cisplatin (Cp) treatment. Male Wistar Kyoto and Sprague Dawley rats were dosed once with 1, 2.5, and 5 ml/kg nephrotoxic serum (NTS) or 1.5 and 5 ml/kg NTS, respectively. GN and tubular damage were observed histopathologically in all treated rats after 14 days. Although serum creatinine and BUN were not changed, several protein BMs and 74 urinary miRNAs were found to be increased 8 and 14 days after NTS administration. Of these 74 miRNAs, 5 were identified as increased after NTS but not after Cp treatment. Using in situ hybridization two of them, miR-10 b and -100, were found to be localized in distal segments of the nephron, potentially reflecting the tubular injury in those regions. Furthermore, evaluation of both miRNA and mRNA expression in the kidney revealed possible miRNA-mRNA interactions mostly associated with fibrotic and transforming growth factor β signaling. In conclusion, our investigations support the potential of urinary miRNAs as specific BMs for kidney injury, and suggest a role of miRNAs in pathological processes during GN in the kidney.
Insights
Urinary microRNAs (miRNAs) show promise as specific biomarkers for kidney injury, differentiating between glomerulonephritis and tubular damage. These findings suggest miRNAs play a role in kidney disease pathology.
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression.
- Their stability in biofluids suggests potential as biomarkers for tissue injury.
- Urinary miRNAs are being explored for detecting site-specific renal damage.
Purpose of the Study:
- To investigate urinary miRNAs as biomarkers for anti-glomerular basement membrane glomerulonephritis (GN) in rats.
- To compare GN-induced urinary miRNA profiles with protein biomarkers and cisplatin-induced tubular injury.
- To explore the role of miRNAs in kidney injury pathology.
Main Methods:
- Induction of GN in rats using nephrotoxic serum (NTS).
- Analysis of urinary miRNAs and protein biomarkers (creatinine, BUN).
- Comparison with previous cisplatin (Cp) treatment data for proximal tubular injury.
- In situ hybridization for miRNA localization and miRNA-mRNA expression analysis in kidney tissue.
Main Results:
- NTS administration led to GN and tubular damage.
- 74 urinary miRNAs were elevated post-NTS, with 5 specific to GN.
- miR-10b and miR-100 localized to distal nephron segments, indicating specific tubular injury.
- miRNA-mRNA interactions linked to fibrotic and TGF-β signaling pathways were identified.
Conclusions:
- Urinary miRNAs can serve as specific biomarkers for kidney injury, distinguishing GN.
- Specific miRNAs like miR-10b and miR-100 may indicate distal nephron damage.
- miRNAs are implicated in the pathological processes of GN.

